[Retracted] Antiviral Therapy with Entecavir following Antituberculosis Therapy Alleviates Liver Injury and Restores Innate Immunity in Tuberculosis Patients Coinfected with Hepatitis B Virus

Table 3

The serum levels of inflammatory cytokines changes between the two groups before treatment and 6 months after treatment.

Group	Time	IFN-γ (ng/L)	TNF-α (ng/L)	IL-6 (ng/L)
Anti-TB group (n = 50)	Before treatment	7.96 ± 1.72	598.19 ± 106.54	123.39 ± 22.31
	6 months after treatment	15.93 ± 2.23	264.74 ± 54.51	58.38 ± 11.34
Antiviral group (n = 50)	Before treatment	7.95 ± 1.64	598.34 ± 105.53	123.36 ± 22.32
	6 months after treatment	23.03 ± 5.16	132.47 ± 22.91	19.52 ± 6.82
t/P (within the anti-TB group)		11.075/0.001	35.091/0.001	24.086/0.001
t/P (within the antiviral group)		17.395/0.001	52.197/0.001	45.394/0.001
t/P (between groups)		9.179/0.001	14.175/0.001	13.187/0.001

TNF-α, tumor necrosis factor-α; IL-6, interleukin-6; IFN-γ, interferon-γ.